NASDAQ:IRTC

iRhythm Technologies Stock Forecast, Price & News

$268.46

+10.85 (+4.21 %)

(As of 01/20/2021 12:00 AM ET)

Add

Compare

Today's Range

$259.87

Now: $268.46▼

$282.64

50-Day Range

$180.80

MA: $222.88▼

$257.61

52-Week Range

$56.54

Now: $268.46▼

$282.64

Volume468,986 shs

Average Volume342,916 shs

Market Capitalization$7.75 billion

P/E RatioN/A

Dividend YieldN/A

Beta1.68

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was founded in 2006 and is headquartered in San Francisco, California.

MarketRank^™

Overall MarketRank^™

1.18 out of 5 stars

Medical Sector

845th out of 1,928 stocks

Surgical & Medical Instruments Industry

83rd out of 170 stocks

2.4 Analyst's Opinion

Consensus Rating
iRhythm Technologies has received a consensus rating of Buy. The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $209.67, iRhythm Technologies has a forecasted downside of 21.9% from its current price of $268.46.
Amount of Analyst Coverage
iRhythm Technologies has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.9 Community Rank

Outperform Votes
iRhythm Technologies has received 342 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
iRhythm Technologies has received 249 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
iRhythm Technologies has received 57.87% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about iRhythm Technologies and other stocks. Vote “Outperform” if you believe IRTC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IRTC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
iRhythm Technologies does not currently pay a dividend.
Dividend Growth
iRhythm Technologies does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, iRhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $18,339,912.00 in company stock.
Percentage Held by Insiders
Only 3.10% of the stock of iRhythm Technologies is held by insiders.

0.6 Earnings and Valuation

Earnings Growth
Earnings for iRhythm Technologies are expected to grow in the coming year, from ($1.56) to ($0.82) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of iRhythm Technologies is -140.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of iRhythm Technologies is -140.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
iRhythm Technologies has a P/B Ratio of 52.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Surgical & medical instruments

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:IRTC

Previous Symbol

CUSIPN/A

CIK1388658

Webwww.irhythmtech.com

Phone415-632-5700

Employees997

Debt

Debt-to-Equity Ratio0.07

Current Ratio6.55

Quick Ratio6.46

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$214.55 million

Price / Sales36.13

Cash FlowN/A

Price / Cash FlowN/A

Book Value$5.09 per share

Price / Book52.74

Profitability

EPS (Most Recent Fiscal Year)($2.16)

Net Income$-54,570,000.00

Net Margins-20.97%

Return on Equity-28.89%

Return on Assets-15.11%

Miscellaneous

Outstanding Shares28,871,000

Market Cap$7.75 billion

Next Earnings Date2/25/2021 (Estimated)

OptionableOptionable

$268.46

+10.85 (+4.21 %)

(As of 01/20/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

iRhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

How has iRhythm Technologies' stock been impacted by COVID-19 (Coronavirus)?

iRhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IRTC stock has increased by 213.8% and is now trading at $268.46.
View which stocks have been most impacted by COVID-19.

Is iRhythm Technologies a buy right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" iRhythm Technologies stock.
View analyst ratings for iRhythm Technologies or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than iRhythm Technologies?

Wall Street analysts have given iRhythm Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but iRhythm Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as iRhythm Technologies' CEO?

1,428 employees have rated iRhythm Technologies CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 59% among iRhythm Technologies' employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is iRhythm Technologies' next earnings date?

iRhythm Technologies is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for iRhythm Technologies.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) posted its quarterly earnings data on Thursday, November, 5th. The company reported ($0.17) EPS for the quarter, beating analysts' consensus estimates of ($0.56) by $0.39. The business earned $71.94 million during the quarter, compared to analyst estimates of $62.34 million. iRhythm Technologies had a negative return on equity of 28.89% and a negative net margin of 20.97%. The firm's quarterly revenue was up 31.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.72) EPS.
View iRhythm Technologies' earnings history.

What price target have analysts set for IRTC?

11 Wall Street analysts have issued 12-month target prices for iRhythm Technologies' shares. Their forecasts range from $130.00 to $273.00. On average, they expect iRhythm Technologies' stock price to reach $209.67 in the next twelve months. This suggests that the stock has a possible downside of 21.9%.
View analysts' price targets for iRhythm Technologies or view Wall Street analyst' top-rated stocks.

Who are some of iRhythm Technologies' key competitors?

Some companies that are related to iRhythm Technologies include Fresenius SE & Co. KGaA (FSNUY), Insulet (PODD), Teleflex (TFX), NovoCure (NVCR), Abiomed (ABMD), Penumbra (PEN), Hill-Rom (HRC), Globus Medical (GMED), Haemonetics (HAE), Nevro (NVRO), Inspire Medical Systems (INSP), Integra LifeSciences (IART), Tandem Diabetes Care (TNDM), Inari Medical (NARI) and ICU Medical (ICUI).
View all of IRTC's competitors.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Square (SQ), Teladoc Health (TDOC), The Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and The Boeing (BA).

Who are iRhythm Technologies' key executives?

iRhythm Technologies' management team includes the following people:

Mr. Kevin M. King, Pres, CEO & Director (Age 64, Pay $1.57M)
Mr. David A. Vort, Exec. VP of Sales (Age 54, Pay $694.3k)
Mr. Mark J. Day Ph.D., Exec. VP of R&D (Age 49, Pay $552.89k)
Mr. Matthew C. Garrett, Advisor (Age 52, Pay $826.03k)
Mr. Douglas J. Devine, CFO & Sec. (Age 50)
Mr. Daniel G. Wilson, Exec. VP of Strategy, Corp. Devel. & Investor Relations
Ms. Marga Ortigas-Wedekind, Exec. VP of Marketing (Age 58)
Ms. Kaja J. Odegard, VP of HR (Age 38)
Ms. Judith C. Lenane, Chief Clinical Officer & Exec. VP of Operations (Age 61)
Mr. Allan B. Wilsker, Exec. VP of Information Technology & Customer Service (Age 61)

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Exchange Traded Concepts LLC (0.03%). Company insiders that own iRhythm Technologies stock include Bruce G Bodaken, David A Vort, Derrick Sung, Kevin M King, Mark J Day, Matthew C Garrett, Merz Cathleen Noel Bairey, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends for iRhythm Technologies.

Which major investors are buying iRhythm Technologies stock?

IRTC stock was bought by a variety of institutional investors in the last quarter, including Exchange Traded Concepts LLC.
View insider buying and selling activity for iRhythm Technologies or or view top insider-buying stocks.

How do I buy shares of iRhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $268.46.

How big of a company is iRhythm Technologies?

iRhythm Technologies has a market capitalization of $7.75 billion and generates $214.55 million in revenue each year. The company earns $-54,570,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis. iRhythm Technologies employs 997 workers across the globe.

What is iRhythm Technologies' official website?

The official website for iRhythm Technologies is www.irhythmtech.com.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here